ADT	Androgen-deprivation therapy
apCAFs	Antigen-presenting cancer-associated fibroblasts
AR	Androgen receptor
BC	Breast carcinoma
CAFs	Cancer-associated fibroblasts
DKK3	Dickkopf-3
ECM	Extracellular matrix
FAPIs	FAP inhibitor
FDA	Food and Drug Administration
FGF	Fibroblast growth factor
FGFR	Fibroblast growth factor receptor
FlnA	Filamin A
ICIs	Immune checkpoint inhibitors
IGFBP	Insulin-like growth factor binding protein
LMO2	LIM domain only 2
mCRPC	Metastatic castration-resistant prostate cancer
MDSCs	Myeloid-derived suppressor cells
MMPs	Matrix-metalloproteinases
MSCs	Mesenchymal stem cells
NKs	Natural killers
PCa	Prostate cancer
PD-1	Programmed cell death protein 1
PDAC	Pancreatic adenocarcinoma
PDL-1	Programmed cell death ligand 1
ROS	Reactive oxygen species
TGF-β	Tumor growth factor β
TIMPs	Tissue inhibitors of matrix metalloproteinases
TME	Tumor microenvironment
VEGFA	Vascular endothelial growth factor A
YAP1	Yes-associated protein 1